ICRP http://www.icrp.org/index.asp International Commission on Radiological Protection en-gb Thu, 17 Aug 2017 05:49:22 +0000 Fukushima Medical University-ICRP Workshop Abstract http://www.icrp.org/docs/FMU-ICRP Workshop Abstract.pdf http://www.irpa.net/docs/FMU-ICRP Workshop Abstract.pdf Fri, 11 Aug 2017 13:52:58 +0000 ICRU Releases Report NO. 91 http://www.icrp.org/docs/ICRU RELEASES REPORT NO. 91.pdf http://www.irpa.net/docs/ICRU RELEASES REPORT NO. 91.pdf Tue, 8 Aug 2017 13:36:14 +0000 Changes in Committee 3 Leadership http://www.icrp.org/page.asp?id=357 <p>Donald Milller, who had been elected to the ICRP Main Commission as Committee 3 Chair, has resigned due to a conflict of interest between his duties as a trustee of ICRP and his obligations to his employer, the US Food and Drug Administration.</p> <p>Colin Martin, ICRP Committee 3 Vice-Chair, is leading the Committee until election of a new Chair.</p> <p>Election of a new Committee 3 Chair will take place during the next meeting of the Main Commission, to be held October 6-8, 2017. This is immediately prior to the 4th International Symposium on the System of Radiological Protection and the 2nd European Radiological Protection Research Week (<a title="ICRP-ERPW 2017" href="http://www.icrp-erpw2017.com/" target="_blank">ICRP-ERPW 2017</a>), taking place in Paris, October 10-12.</p> Thu, 3 Aug 2017 22:20:12 +0000 Draft Joint Report of ICRU and ICRP for Consultation: Operational Quantities for External Radiation Exposure http://www.icrp.org/page.asp?id=356 <p><span style="font-size: 10pt;">The draft </span><strong style="font-size: 10pt;">ICRU and ICRP report Operational Quantities for External Radiation Exposure</strong><span style="font-size: 10pt;"> is now available for public consultation.&nbsp; We welcome comments from individuals and organisations.&nbsp; The draft document can be downloaded from the ICRP website.&nbsp; Comments must be submitted through the ICRP website no later than </span><strong style="font-size: 10pt;">November 3, 2017</strong><span style="font-size: 10pt;">.</span></p> <p class="MsoNormal">&nbsp;</p> <p class="MsoNormal">&nbsp;</p> <p class="MsoNormal"><strong>Abstract</strong></p> <p>&nbsp;</p> <p class="MsoNormal">The Commission defines a set of&nbsp;operational dose quantities for the determination of the exposure of external&nbsp;radiation by measurement or calculation. These assessments serve as estimates of&nbsp;values&nbsp;of the protection quantities defined by the International Commission on&nbsp;Radiological Protection (ICRP) that are generally not measurable. The set of&nbsp;ICRU operational dose quantities in current use&nbsp;was defined 30 years ago. The&nbsp;rationale for operational quantities has been examined taking into account the&nbsp;recent changes in the definitions of the protection quantities (ICRP, 2010);&nbsp;the changes in&nbsp;the fields of application of the operational quantities and&nbsp;protection quantities in medicine, scientific research, and natural sources of&nbsp;radiation; and the extension of types of particles and range of&nbsp;energies&nbsp;contributing to doses to workers and members of the public. The previous&nbsp;operational quantities were based on the dose equivalent that would be produced&nbsp;at a depth in the hypothetical&nbsp;ICRU 4-element sphere, and on dose equivalent in&nbsp;soft tissue at a point in the body. The investigations which have been carried&nbsp;out that have led to the recommendations given in this Report have&nbsp;included the&nbsp;study the values of weighted absorbed doses at different depths in&nbsp;tissue-equivalent phantoms and the combination of different depths. The&nbsp;operational quantities recommended in this&nbsp;Report are defined in terms of radiometric&nbsp;and dosimetric quantities at a point in space multiplied by values of&nbsp;conversion coefficients to the protection quantities, effective dose, absorbed&nbsp;dose in the&nbsp;lens of the eye, and absorbed dose in local skin, calculated for&nbsp;broad parallel beams incident on the body. The relationship of the recommended&nbsp;operational quantities to the protection quantities has&nbsp;been investigated. The&nbsp;impact of changes on routine measurement practice, including instrument design and&nbsp;calibration has been considered.</p> <p class="MsoNormal">While this will be published by ICRU, questions and inquiries can be directed to <a href="mailto:kelsey.cloutier@icrp.org">Kelsey Cloutier</a>, Development and Communications Manager for ICRP.</p> Wed, 2 Aug 2017 11:45:56 +0000 Release of Publication 134: Occupational Intakes of Radionuclides: Part 2 http://www.icrp.org/page.asp?id=354 <h1>Occupational Intakes of Radionuclides: Part 2</h1> <h2>ICRP Publication 134</h2> <p><span style="font-size: 12px;">Ann. ICRP 45(3/4), 1&ndash;352, 2016</span><br style="font-size: 12px;" /><br style="font-size: 12px;" /><span style="font-size: 12px;">F. Paquet, M.R. Bailey, R.W. Leggett, J. Lipsztein, T.P. Fell,T. Smith, D. Nosske, K.F. Eckerman, V. Berkovski, E. Ansoborlo,A. Giussani, W.E. Bolch, J.D. Harrison</span><br style="font-size: 12px;" /><br style="font-size: 12px;" /><br style="font-size: 12px;" /><strong style="font-size: 12px;">Abstract -</strong><span style="font-size: 12px;">&nbsp;The 2007 Recommendations of the International Commission on Radiological Protection (ICRP, 2007) introduced changes that affect the calculation of effective dose, and implied a revision of the dose coefficients for internal exposure, published previously in thePublication 30series (ICRP, 1979, 1980, 1981, 1988b) and Publication 68(ICRP, 1994b). In addition, new data are available that support an update of the radionuclide-specific information given in Publications 54 and 78 (ICRP, 1988a, 1997b) for the design of monitoring programmes and retrospective assessment of occupational internal doses. Provision of new biokinetic models, dosecoefficients, monitoring methods, and bioassay data was performed by Committee 2, Task Group 21 on Internal Dosimetry, and Task Group 4 on Dose Calculations. A new series, the Occupational Intakes of Radionuclides (OIR) series, will replace the Publication 30series and Publications 54,68, and 78. Part 1 of the OIR series has been issued (ICRP, 2015), and describes the assessment of internal occupational exposure to radionuclides, biokinetic and dosimetric models, methods of individual and workplace monitoring, and general aspects of retrospective dose assessment. The following publications in the OIR series (Parts 2&ndash;5) will provide data on individual elements and their radioisotopes, including information on chemical forms encountered in the workplace; a list of principal radioisotopes and their physical half-lives and decay modes; the parameter values of the reference biokinetic model; and data on monitoring techniques for the radioisotopes encountered most commonly in workplaces. Reviews of data on inhalation, ingestion, and systemic biokinetics are also provided for most of the elements. Dosimetric data provided in the printed publications of the OIR series include tables of committed effective dose perintake (Sv per Bq intake) for inhalation and ingestion, tables of committed effective dose per content (Sv per Bq measurement) for inhalation, and graphs of retentionand excretion data per Bq intake for inhalation. These data are provided for all absorption types and for the most common isotope(s) of each element. The electronic annex that accompanies the OIR series of reports contains a comprehensive set of committed effective and equivalent dose coefficients, committed effective dose percontent functions, and reference bioassay functions. Data are provided for inhalation, ingestion, and direct input to blood. The present publication provides the above data for the following elements: hydrogen (H), carbon (C), phosphorus (P),sulphur (S), calcium (Ca), iron (Fe), cobalt (Co), zinc (Zn), strontium (Sr), yttrium(Y), zirconium (Zr), niobium (Nb), molybdenum (Mo), and technetium (Tc).</span><br style="font-size: 12px;" /><br style="font-size: 12px;" /></p> <h3>Recommended reference format for citations</h3> <p><span style="font-size: 12px;">ICRP, 2016. Occupational intakes of radionuclides: Part 2. ICRP Publication 134. Ann. ICRP 45(3/4), 1&ndash;352.</span><br style="font-size: 12px;" /></p> Tue, 11 Jul 2017 12:47:30 +0000 ICRP Research Priorities 2017 http://www.icrp.org/docs/ICRP Research Priorities 2017.pdf http://www.irpa.net/docs/ICRP Research Priorities 2017.pdf Tue, 27 Jun 2017 17:56:44 +0000 Joint FMU-ICRP Workshop on Radiological Protection in Medicine http://www.icrp.org/docs/Joint FMU-ICRP Workshop Oct 2017 First Announcement.pdf http://www.irpa.net/docs/Joint FMU-ICRP Workshop Oct 2017 First Announcement.pdf Thu, 22 Jun 2017 13:38:37 +0000 ICRP Announces Committee Membership for 2017-2021 http://www.icrp.org/page.asp?id=353 <p class="MsoNormal"><span>In December 2016, ICRP advertised an open call for nominations for Committee membership for the coming term. A large number of excellent nominations were received, each of which was considered carefully by all Main Commission members. We sincerely thank everyone who was nominated for their interest in ICRP.</span></p> <p class="MsoNormal"><span>Last May, the Main Commission voted to select those to be invited to be Committee members for the July 1, 2017 to June 30, 2021 term. Invitations were sent, as were letters of thanks to those who were not elected. Those not elected will be considered when looking for specific expertise for ICRP Task Groups.</span></p> <p class="MsoNormal"><span>It is with great enthusiasm that we welcome and congratulate the following individuals who have accepted their invitations to join an ICRP Committee:</span></p> <p class="MsoNormal"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Committee 1 (Radiation Effects)</strong></span></p> <p class="MsoListParagraphCxSpFirst" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Werner R&uuml;hm (Chair)</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Tamara Azizova</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Ranajit Chakraborty</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Wolfgang D&ouml;rr</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Jaqueline Garnier-Laplace</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Michael Hauptmann</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Kotaro Ozasa</span></p> <p>&nbsp; Preetha Rajarama</p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Kazuo Sakai</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Sisko Salomaa</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Mikhail Sokolnikov</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Daniel Stram</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Quanfu Sun</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Richard Wakeford</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Andrzej Wojcik</span></p> <p class="MsoListParagraphCxSpLast" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Gayle Woloschak</span></p> <p class="MsoNormal" style="margin-left: 36.0pt;"><strong><span>Committee 2 (Doses from Radiation Exposure)</span></strong></p> <p class="MsoListParagraphCxSpFirst" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>John Harrison (Chair)</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Volodymyr Berkovski</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Eric Blanchardon</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Wesley Bolch</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Fran&ccedil;ois Paquet</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Augusto Giussani</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Nina Petoussi-Hen&szlig;</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Derek Jokisch</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Chan Hyeong Kim</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Rich Leggett</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Maria Lopez</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Junli Li</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Tatsuhiko Sato</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Tracy Smith</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Alexander Ulanowski</span></p> <p class="MsoListParagraphCxSpLast" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Frank Wissmann</span></p> <p class="MsoNormal" style="margin-left: 36.0pt;"><strong><span>Committee 3 (Protection in Medicine)</span></strong></p> <p class="MsoListParagraphCxSpFirst" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Donald Miller (Chair)</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Jamila Al Suwaidi</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Kimberly Applegate</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Michel Bourguignon</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Marie-Claire Cantone</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Sandor Demeter</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Makoto Hosono</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Keon Wook Kang</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Reinhard Loose</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Josep Mart&iacute;-Climent</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Colin Martin</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Yantao Niu</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Madan Rehani</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>William Small</span></p> <p class="MsoListParagraphCxSpLast" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>David Sutton</span></p> <p class="MsoNormal" style="margin-left: 36.0pt;"><strong><span>Committee 4 (Application of the Commission&rsquo;s Recommendations)</span></strong></p> <p class="MsoListParagraphCxSpFirst" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Donald Cool (Chair)</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Nobuhiko Ban</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Fran&ccedil;ois Bochud</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Michael Boyd</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Analia Canoba</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>David Copplestone</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Eduardo Gallego</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Kathryn Higley</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Gillian Hirth</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Toshimitsu Homma</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Catrin Koch</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Jean-Fran&ccedil;ois Lecomte</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Yahong Mao</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Nicole Martinez</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Anne Nisbet</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Thierry Schneider</span></p> <p class="MsoListParagraphCxSpMiddle" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>Sergey Shinkarev</span></p> <p class="MsoListParagraphCxSpLast" style="text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!--[if !supportLists]-->-<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><!--[endif]--><span>John Takala</span></p> <p class="MsoNormal" style="margin-top: 12.0pt;"><span>As announced last <a href="docs/Committees%20Announcement.pdf">November</a>, ICRP is working to further integrate protection of people and the environment. To reflect this, Committees 1, 2, and 4 are taking on responsibilities in radiological protection of the environment formerly undertaken by Committee 5.</span></p> <p class="MsoNormal"><span>A decision was made to begin the term with a slightly smaller overall Committee membership than before. This will make it easier to take advantage of opportunities during the term to add a few members to include particular expertise, or to further improve geographical and gender balance. </span></p> <p class="MsoNormal"><span>Please note that a few members-elect are still in the process of accepting their invitations, so a few additions may still be made to the Committee membership listed above.</span></p> <p class="MsoNormal"><span>Questions can be directed to <a href="mailto:kelsey.cloutier@icrp.org">Kelsey Cloutier</a>, ICRP Development and Communications Manager.</span></p> Wed, 21 Jun 2017 16:37:43 +0000 Summary of May 2017 Main Commission Meeting Lima http://www.icrp.org/docs/Summary of May 2017 Main Commission Meeting Lima.pdf http://www.irpa.net/docs/Summary of May 2017 Main Commission Meeting Lima.pdf Mon, 12 Jun 2017 13:54:53 +0000 ICRP Welcomes Dr. R. Julian Preston as Emeritus Member http://www.icrp.org/docs/Emeritus Member Announcement 2017.pdf http://www.irpa.net/docs/Emeritus Member Announcement 2017.pdf Fri, 19 May 2017 13:59:03 +0000 ICRP Announces Main Commission for Next Term http://www.icrp.org/page.asp?id=351 <p class="MsoNormal" style="margin-bottom: 8.0pt; line-height: 11.65pt;">The ICRP Main Commission and Committees operate on fixed four-year terms, with the current term ending on June 30, 2017.</p> <p class="MsoNormal" style="margin-bottom: 8.0pt; line-height: 11.65pt; text-decoration: -webkit-letterpress;">Turnover is a natural part of this process, bringing in new people with new ideas, to compliment those with years of experience in ICRP.&nbsp;</p> <p class="MsoNormal" style="margin-bottom: 8.0pt; line-height: 11.65pt; text-decoration: -webkit-letterpress;">Last week, Main Commission and Committee members were elected for the July 1, 2017 to June 30, 2021 term. We are pleased to announce the membership for the Main Commission:</p> <p class="MsoNormal" style="mso-margin-top-alt: auto; margin-bottom: 8.0pt; margin-left: 38.5pt; text-indent: -18.0pt; line-height: 13.5pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!--[if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang="EN-US">Claire Cousins (Chair), United Kingdom</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto; margin-bottom: 8.0pt; margin-left: 38.5pt; text-indent: -18.0pt; line-height: 13.5pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!--[if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang="EN-US">Jacques Lochard (Vice-Chair), France</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto; margin-bottom: 8.0pt; margin-left: 38.5pt; text-indent: -18.0pt; line-height: 13.5pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!--[if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang="EN-US">Werner R&uuml;hm (C1 Chair), Germany</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto; margin-bottom: 8.0pt; margin-left: 38.5pt; text-indent: -18.0pt; line-height: 13.5pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!--[if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang="EN-US">John Harrison (C2 Chair), United Kingdom</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto; margin-bottom: 8.0pt; margin-left: 38.5pt; text-indent: -18.0pt; line-height: 13.5pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!--[if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang="EN-US">Donald Miller (C3 Chair), USA</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto; margin-bottom: 8.0pt; margin-left: 38.5pt; text-indent: -18.0pt; line-height: 13.5pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!--[if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang="EN-US">Donald Cool (C4 Chair), USA</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto; margin-bottom: 8.0pt; margin-left: 38.5pt; text-indent: -18.0pt; line-height: 13.5pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!--[if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang="EN-US">Simon Bouffler, United Kingdom</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto; margin-bottom: 8.0pt; margin-left: 38.5pt; text-indent: -18.0pt; line-height: 13.5pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!--[if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang="EN-US">Kunwoo Cho, South Korea</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto; margin-bottom: 8.0pt; margin-left: 38.5pt; text-indent: -18.0pt; line-height: 13.5pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!--[if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang="EN-US">Michiaki Kai, Japan</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto; margin-bottom: 8.0pt; margin-left: 38.5pt; text-indent: -18.0pt; line-height: 13.5pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!--[if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang="EN-US">Carl-Magnus Larsson, Australia</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto; margin-bottom: 8.0pt; margin-left: 38.5pt; text-indent: -18.0pt; line-height: 13.5pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!--[if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang="EN-US">Dominique Laurier, France</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto; margin-bottom: 8.0pt; margin-left: 38.5pt; text-indent: -18.0pt; line-height: 13.5pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!--[if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang="EN-US">Senlin Liu, China</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto; margin-bottom: 8.0pt; margin-left: 38.5pt; text-indent: -18.0pt; line-height: 13.5pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!--[if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang="EN-US">Sergey Romanov, Russia</span></p> <p class="MsoNormal" style="margin-bottom: 8.0pt; line-height: 11.65pt; text-decoration: -webkit-letterpress;">Many thanks to John Boice, Jaiki Lee, Hua Liu, Hans-Georg Menzel, Ohtsura Niwa, and Eliseo Vano for their many years of dedication to ICRP and the field of Radiological Protection while serving as members of the Main Commission.&nbsp; We wish them all the best as they join the ranks of distinguished ICRP alumni on July 1st.&nbsp;</p> <p class="MsoNormal" style="margin-bottom: 8.0pt; line-height: 11.65pt; text-decoration: -webkit-letterpress;">Individuals elected to the four ICRP Committees will receive invitations in the coming weeks. We look forward to announcing the results once their membership has been confirmed.&nbsp;</p> <p class="MsoNormal" style="margin-bottom: 8.0pt; line-height: 11.65pt; text-decoration: -webkit-letterpress;">The total number of Committee members receiving invitations has decreased slightly from previous years. This gives us more flexibility to consider a few additional members during the term, to bring in expertise as needed, and to continue to improve the diversity of our membership.&nbsp;</p> <p class="MsoNormal" style="margin-bottom: 8.0pt; line-height: 11.65pt; text-decoration: -webkit-letterpress;"><span style="font-size: 10pt;">Any questions can be directed to <a href="mailto:kelsey.cloutier@icrp.org">Kelsey Cloutier</a>, Development and Communications Manager.</span></p> <p class="MsoNormal" style="margin-bottom: 8.0pt; line-height: 11.65pt; text-decoration: -webkit-letterpress;">&nbsp;</p> Wed, 17 May 2017 22:18:31 +0000 ICRP Welcomes New Intern: Julie Reyjal http://www.icrp.org/page.asp?id=350 <p>On May 1st, ICRP welcomed Julie Reyjal to the Scientific Secretariat team.</p> <p>Similar to past situations, the Canadian Nuclear Safety Commission (CNSC) have graciously provided this resource cost-free. &nbsp;However, Julie comes to the Secretariat already an accomplished Radiation and Health Sciences Officer in the&nbsp;Radiation and Health Sciences Division, Directorate of Environmental and Radiation Protection and Assessment,&nbsp;Technical Support Branch of the Canadian government.</p> <p>A native of New Brunswick, Julie has completed a BSc in Biochemistry and Biology from Mount Allison University, as well as her Masters in Biochemistry from the Universit&eacute; de Moncton.</p> <p>While at ICRP, Julie will be working with Dr. Gayle Woloschak and her research team at Northwestern University doing data mining in order to investigate Dose and Dose-Rate Effectiveness Factor (DDREF).</p> <p>Once again, thank you to the CNSC for their partnership, collaboration, and support.</p> <p>Welcome Julie!</p> Wed, 3 May 2017 13:51:42 +0000 Draft Report for Consultation: Ethical Foundations of the System of Radiological Protection http://www.icrp.org/page.asp?id=349 <p>Effective today, the draft report on Ethical Foundations of the System of Radiological Protection&nbsp;is available for public consultation.&nbsp; The following is the abstract included in the report:</p> <p>"Despite a long recognition that radiological protection is not only a matter of science, but also morality and wisdom, ICRP publications have rarely addressed the ethical foundations of the system of radiological protection explicitly. The purpose of this publication is to describe how the Commission has used ethical values in developing the system of radiological protection with the objective of presenting a coherent view of how ethics is part of this system. In so doing it helps to clarify the inherent value judgements made in achieving the aim of the radiological protection system as underlined by the Commission in its Publication 103. Although primarily addressed to the radiological protection community, this publication is also intended to address authorities, operators, workers, medical professionals, patients, the public and its representatives acting in the interest of the protection of people and the environment. The publication provides first the key steps concerning the scientific, ethical and practical evolutions of the system of radiological protection since the first ICRP publication in 1928. It then describes the four core ethical values underpinning the present system: beneficence/non-maleficence, prudence, justice, and dignity. It also discusses how these core ethical values relate to the principles of radiological protection, namely justification, optimisation, and limitation. The publication finally addresses key procedural values that are required for the practical implementation of the system, focusing on accountability, transparency and inclusiveness. The Commission sees this publication as a founding document to be elaborated further in different situations and circumstances."&nbsp;</p> <p>In keeping with ICRP&rsquo;s longstanding commitment to being open, inclusive, and transparent, the consultation will be available for a period of 90 days.&nbsp; You can find the draft report and provide comments <a href="page.asp?id=348">here</a>. Comments must be provided through the website by individuals or organisations no later than July 21, 2017.</p> <p>Further questions and inquiries should be directed towards&nbsp;<a href="mailto:kelsey.cloutier@icrp.org">Kelsey Cloutier</a>, Development and Communications Manager.</p> <p>&nbsp;</p> Thu, 20 Apr 2017 17:38:30 +0000 NRPA Announces Second Legacy Workshop in Cooperation with ICRP, IAEA, NEA, and IUR http://www.icrp.org/docs/NRPA 2nd Legacy Workshop.pdf http://www.irpa.net/docs/NRPA 2nd Legacy Workshop.pdf Wed, 19 Apr 2017 17:01:41 +0000 ICRP Seeks Cost-Free Staff Loan for the Position of Assistant Scientific Secretary http://www.icrp.org/page.asp?id=347 <p style="text-align: left;"><span style="font-size: 10pt; text-align: left;">In 2012, ICRP established the position of Assistant Scientific Secretary. Since then, it has been filled through three consecutive cost-free staff loans of two years each. The term of the current incumbent ends in March 2018.</span></p> <p><span style="font-size: 10pt;">Under direct supervision of the Scientific Secretary, and based in the ICRP offices in Ottawa, Canada, the Assistant Scientific Secretary is responsible for duties including:</span></p> <ul> <li><span style="font-size: 10pt;">Associate Editor of the Annals of the ICRP;</span></li> <li><span style="font-size: 10pt;">Coordinating and participating in ICRP meetings and other events internationally, including meetings of the ICRP Main Commission; and,</span></li> <li><span style="font-size: 10pt;">General administration of the ICRP Scientific Secretariat.</span></li> </ul> <!--[if !supportLists]--> <p><span style="font-size: 10pt;">Incumbents have a unique opportunity to gain insight into the workings of ICRP and the system of radiological protection, and benefit from interactions with ICRP members and other top experts in radiological protection worldwide.</span></p> <p><span style="font-size: 10pt;">ICRP is now seeking expressions of interest from organisations interested in providing a cost-free staff loan for the position of ICRP Assistant Scientific Secretary.</span></p> <p><span style="font-size: 10pt;">Specific terms will be negotiated, but a period of two to three years is ideal. The loaning organisation covers salary, benefit, living, and relocation costs, while ICRP provides a welcoming working environment, business travel costs, and an exceptional and enriching experience.</span></p> <p><span style="font-size: 10pt;">As this posting is in Canada, candidates other than Canadian citizens or permanent residents need to receive a Canadian work permit prior to commencing work.</span></p> <p><strong><span style="font-size: 10pt;">Organisations wishing to express an interest should contact the undersigned by October 31, 2017 at the latest.</span></strong></p> <p>&nbsp;</p> <p>The PDF can be found <a href="admin/ICRP%20Seeks%20Cost-Free%20Staff%20Loan%202017.pdf">here</a>&nbsp;for distribution.</p> <p><img src="admin/Clement.jpg" alt="" width="108" height="68" /></p> <p>Christopher Clement</p> <p>Scientific Secretary</p> <p>(613) 947-9750</p> <p class="MsoNormal" style="text-align: justify;"><a href="mailto:sci.sec@icrp.org">sci.sec@icrp.org</a></p> Mon, 10 Apr 2017 15:51:12 +0000 Series of ICRP Publications Now Available in Japanese http://www.icrp.org/page.asp?id=345 <p>Thanks to the tremendous efforts of the Japanese Radioisotope Association, the following ICRP publications are now available in Japanese: &nbsp;</p> <ul> <li><strong>Publication 115</strong></li> <li><strong>Publication 117&nbsp;&nbsp;</strong></li> <li><strong>Publication 120&nbsp;</strong></li> <li><strong>Publication 122&nbsp;</strong></li> <li><strong>Supporting Guidance 2</strong></li> </ul> <p>Additionally, the following publications are to become available in the coming weeks:</p> <ul> <li><strong>Publication 108</strong></li> <li><strong>Publication 118</strong></li> </ul> <p>With ICRP's priority of promoting the System of Radiological Protection and broadening access to recommendations, initiatives such as these translations undoubtedly assist towards more global outreach and engagement. &nbsp;Currently, there are now over 25 publications translated into the Japanese language.</p> <p>Translations of selected ICRP publications are also available in: Arabic, Chinese, French, German, Italian, Korean, Romanian, Russian, and Spanish.</p> <div>For more information, and to access these and all other publications, please visit our&nbsp;<a href="publications.asp">website</a>.</div> Fri, 31 Mar 2017 14:07:37 +0000 Members of ICRP Continue Dialogue Six Years after Fukushima Daiichi Nuclear Power Plant Accident http://www.icrp.org/page.asp?id=344 <p style="text-align: center;"><img src="admin/Dialogue%20MAR%202017.jpg" alt="" width="640" height="480" /></p> <p>&nbsp;</p> <p>&nbsp;</p> <p style="text-align: justify;">Thanks to the generous support of the Nippon Foundation and Fukushima Medical University, senior members of ICRP&nbsp;participated in dialogue meetings on the 6th&nbsp;anniversary of the Great East Japan Earthquake and Fukushima Daiichi&nbsp;Nuclear Power Plant accident. The topic of this dialogue meeting, the sixteenth organised by or in cooperation with ICRP&nbsp;since the accident, was &lsquo;sharing the current situations of local near the intermediate storage facilities in Futaba and Okuma&nbsp;Towns and surrounding areas&rsquo;. The first twelve dialogue meetings were led by ICRP and organised in cooperation with&nbsp;many international, national, and local stakeholders. More recently, the dialogues have been organised locally, in&nbsp;cooperation with ICRP.<br /> &nbsp;<br /> Claire Cousins (Chair), Jacques Lochard (Vice-Chair), Christopher Clement (Scientific Secretary), and Haruyuki Ogino&nbsp;(Assistant Scientific Secretary) met with local experts, officials, and citizens on March 11th&nbsp;and 12th, 2017. &nbsp;A field tour was&nbsp;conducted on Saturday March 11th&nbsp;in Futaba Town, followed by dialogue open to the public in Naraha Town on the 12th.&nbsp;Affected parties were given the opportunity to share their concerns, frustrations, and hopes for the future.<br /> &nbsp;<br /> During their visit to Japan, Cousins, Lochard, Clement, and Ogino also had the pleasure of meeting with Nippon&nbsp;Foundation Chairman Yohei Sasakawa, Fukushima Medical University President Shinichi Kikuchi, Date City Mayor Shoji Nishida,&nbsp;CRIEPI President Masahiro Kakumu, RERF Chairman Ohtsura Niwa, and members of the Support Team for Residents&nbsp;Affected by Nuclear Incidents of the Japanese Cabinet Office.</p> Thu, 23 Mar 2017 17:39:14 +0000 Draft Report Available for Consultation http://www.icrp.org/page.asp?id=341 <p><span style="font-family: Times New Roman; font-size: small;"> </span></p> <p>Effective today, the draft report on Occupational Radiological Protection in Interventional Procedures is available for public consultation.&nbsp; The following is an excerpt from the purpose and scope of the report included in the Executive Summary:</p> <p>&ldquo;In Publications 117 (ICRP, 2010a) and 120 (ICRP, 2013a), the Commission provided practical advice on occupational radiological protection for physicians and other health care personnel involved in fluoroscopically-guided interventions. The current document provides guidance on exposure monitoring strategies, methods and options, radiological protection approaches and garments, their use and testing, the development of a radiological protection programme, education and training and quality assurance of the programme implementation. The guidance is meant for medical physicists and other healthcare professionals in charge of occupational protection, personnel working in dosimetry services, clinical applications support personnel, regulators and all those having an influence on the overall safety culture and on quality assurance and improvement. In addition, the guidance will be useful to those engaged in training, standardisation of equipment and procedures, to those with responsibilities for occupational health and to hospital managers and administrators responsible for providing financial support for protection purposes and to professional bodies (interventionalists, medical physicists, nurses, radiographers).&rdquo;</p> <p>In keeping with ICRP&rsquo;s longstanding commitment to being open, inclusive, and transparent, the consultation will be available for a period of 90 days.&nbsp; You can find the draft report and provide comments <a href="page.asp?id=340">here</a>.&nbsp; Comments must be provided through the website by individuals or organisations no later than June 23, 2017.</p> <p>Further questions and inquiries should be directed towards <a href="mailto:kelsey.cloutier@icrp.org">Kelsey Cloutier</a>, Development and Communications Manager.</p> <p><span style="font-family: Times New Roman; font-size: small;"> </span></p> Tue, 21 Mar 2017 14:52:10 +0000 FINAL REMINDER: ICRP Nomination Deadline One Week Away http://www.icrp.org/page.asp?id=339 <p>As previously released on December 8th, 2016, ICRP is now seeking nominations for Committee membership for the next term: July 1, 2017 to June 30, 2021. Nominations will be retained for consideration for membership in ICRP Task Groups as the need arises.</p> <p><strong>Nominations must be submitted by email to nominations@icrp.org no later than February 28, 2017</strong>. A nomination may be submitted by any person. It must be a pdf file of no more than 2 pages in length, in English (the working language of ICRP), and must include the following information:</p> <p style="padding-left: 30px;">a) The name, country of residence, affiliation (normally the employer), and contact information, including e-mail address, of the nominee;</p> <p style="padding-left: 30px;">b) An indication of the Committee(s) for which the nominee is being nominated;</p> <p style="padding-left: 30px;">c) A short CV of the nominee including at least a brief employment history, list of relevant major professional accomplishments, publications, and other information describing how they meet the relevant qualifications for the Committee;</p> <p style="padding-left: 30px;">d) The names and contact information, including e-mail addresses, of two nominators (any person other than the nominee may be a nominator &ndash; nominators may be contacted in confidence by ICRP for further information); and,</p> <p style="padding-left: 30px;">e) A declaration that the nominee is aware of the nomination.</p> <p>Receipt of nominations will be acknowledged by return e-mail (to the address from which the nomination was received). <strong>Nominations should be sent well in advance of the strict deadline of February 28, 2017 in case time is needed to resolve any difficulties, since nominations not meeting the criteria outlined above will not be considered</strong>. Similarly, a nomination will not be considered if nominators cannot be contacted. Note that current ICRP Committee members are asked to follow the same procedure should they wish to continue to serve on a Committee.</p> <p>The ICRP Main Commission will evaluate the nominations, and select individuals for Committee membership for the 2017 &ndash; 2021 term through an election process. Invitations will be sent to those selected during the second quarter of 2017. The first meetings of the Committees will be in Paris October 9-15, 2017.</p> <p>An example for nomination submissions can be found at the end of the document <a href="docs/ICRP%20Call%20for%20Nominations%202017.pdf">here</a>, along with all pertinent nomination information.<strong></strong><em></em></p> Tue, 21 Feb 2017 15:23:05 +0000 Series of ICRP Publications Now Available in Korean http://www.icrp.org/page.asp?id=338 <p>Thanks to the&nbsp;hard work of Jaiki Lee and KARP (Korean Association for Radiation Protection), the following ICRP publications are now available in Korean:</p> <ul> <li><strong>Publication 117</strong>: Radiological Protection in Fluoroscopically Guided Procedures outside the Imaging Department</li> <li><strong>Publication 120</strong>: Radiological Protection in Cardiology </li> <li><strong>Publication 121</strong>: Radiological Protection in Paediatric Diagnostic and Interventional Radiology</li> <li><strong>Publication 122</strong>: Radiological Protection in Geological Disposal of Long-lived Solid Radioactive Waste</li> <li><strong>Publication 125</strong>: Radiological Protection in Security Screening</li> <li><strong>Publication 126</strong>: Radiological Protection against Radon Exposure</li> </ul> <p>With ICRP's priority of promoting awareness of radiological protection and broadening access to recommendations, initiatives such as these translations undoubtedly assist towards more global outreach and engagement.</p> <p>For more information, and to access these and all other publications, please visit our <a href="publications.asp">website</a>.</p> Mon, 13 Feb 2017 17:06:36 +0000